MENA PharmaMarket

download MENA PharmaMarket

of 20

  • date post

    08-Apr-2015
  • Category

    Documents

  • view

    182
  • download

    5

Embed Size (px)

Transcript of MENA PharmaMarket

GENERICS Opportunities & Challenges

in the MENA Region

General Director JPD AND Hanan Sboul Secretary General JAPMArab German Health Forum Hamburg 20- 21 October, 2009

Maisa Saket

OUTLINE

Pharmaceutical market overview Jordanian Pharmaceutical Industry Challenges Opportunities

2

Pharmaceutical market in MENA region Total Pharmaceutical Market exceeds US$ 12.0 billion 2% of the worlds pharmaceutical market Total Population 340 million Total GDP 1.911 US$ Trillion (2008) Approx. 3% of the worlds GDP

3

Pharmaceutical market in MENA region 280 pharmaceutical manufacturers producing mainly generics in different therapeutic categories Antibiotics are the leading therapeutic class followed by NSAIDs Demand for pharmaceuticals is largely covered by imports Governments are the major health care provider

4

Total Pharmaceutical Market 2008*Country KSA Egypt Iraq GCC Algeria Morocco Syria Tunisia Yemen Libya Lebanon Sudan Jordan Palestine Total Total Market (US$) 2,420,000,000 1,980,000,000 1,300,000,000 1,198,000,000 1,020,000,000 920,000,000 710,000,000 519,000,000 500,000,000 430,000,000 375,000,000 302,000,000 202,554,500 190,000,000 12,066,554,500 Share % 20.06% 16.41% 10.77% 9.93% 8.45% 7.62% 5.88% 4.30% 4.14% 3.56% 3.11% 2.50% 1.68% 1.57% No. of Manufacturers 17 68 10 7 17 23 60 27 6 1 6 16 16 6 280* Source: AUPAM

5

MENA Pharmaceutical Markets

MENA markets by value (US$ million)*$2,420 $1,980

$1,300

$1,198 $1,020 $920 $710 $519 $500 $430 $375 $302 $325 $190

GCC

Morocco

Tunisia

Egypt

Lebanon

* Source: AUPAM

Palestine

Syria

Iraq

Yemen

Algeria

Jordan

Libya

Sudan

KSA

6

Average Consumption per Capita in MENA

Average consumption per capita in the MENA Countries *$34 $25 $27 $28 $30 $31

$18

$20

$21

$22

$23

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007* Source: AUPAM

7

Average Consumption Per Capita in the world

$911

$808

Average consumption per capita in the world (2007) *$450

$235

$229

$114

$88 $34 $38 $19Indian sub continent

$13Africa (southern)

North America

Japan

Western Europe

Israel

Australia

Central and Eastern Europe

Latin America

MENA Countries

China / Eastern Asia

* Source: AUPAM

8

MENA Pharma ExportsJordan leading the MENA pharmaceutical exportsMENA pharmaceutical exports are almost US $1 billion. Jordan is the leader with projected exports of $ 480 millions in 2009 Going forward, Jordanian pharmaceuticals due to are widely accept due to Quality and Value Good prices$110 $80 $15Jo rdan Egypt Saudi UA E Syria Lebano n

Value of exports 2007 (US$ million) *

$359 $300

$210

Manpower, direct sales operations in export markets

* Source: AUPAM

9

Jordanian Pharmaceutical Industry

Started in 1962 16 companies, 17 branches outside Jordan

Export oriented; to 66 export markets. Major export markets are Saudi Arabia, Algeria, Iraq, Libya & the GulfLocal market share; 50% in volume & 28% in value

Essential for Jordan economy; employment & export

10

Jordanian Pharmaceutical Industry

Employment

5310 employees & 3000 in supporting industry 99% Jordanians 39% are females 31% hold degrees

Investment

$400m in Jordan & $200m outside Branches in 17 countries11

Jordanian Pharmaceutical Industry

Exportation

75% for export Around 60 countries $490 m in 2008 20% annual increase 8% of Jordan exports Positive trade balance

12

Pharmaceutical exports, million $500 450 400 350 300 250 200 150 100 50 180 235 250 432 490

280

300

200

200

02000 2002 2004 2006 2008

13

Target 1 bn USD in 2011

Export markets for Jordanian Pharmaceuticals 2008

14

10/17/2009

14

Strategic alliances with international firms

15

10/17/2009

15

ChallengesManufacturing costs Cost of compliance Strong competition Emerging local industries Price control and price erosions Fragmented regulatory regimes

16

Opportunities IGrowth Drivers in MENA

Population growth- higher than average (2.7% ) Growing economies, high purchasing power Focus on healthcare and increased spending on healthcare facilities by governments Mandatory health insurance schemes Demographic trends: increase in life expectancy, literacy rates and prevalence of life style related diseases like diabetes & cardiovascular, diseases which constitute around 18-22 percent of total pharmaceutical volume.

17

Opportunities IIAccess to markets through licensing arrangements, joint ventures and partnerships with local firm, with

Skilled labor, relatively lower wages Lower manufacturing costs compared to US & EU High standards manufacturing sites; GMP compliant Accumulated regulatory and marketing expertise

18

Opportunities IIINew therapeutic areas are key growth drivers, such as

o

Biotechnology products

o

HormonesInjectables

o

19

Thank You

The Jordanian Association of Pharmaceutical Manufacturers www.japm.com info@japm.com